Interferon-γ-inducing factor (IL-18) and interferon-γ in inflammatory CNS diseases / K. Fassbender, O. Mielke, T. Bertsch, F. Muehlhauser, M. Hennerici, M. Kurimoto, and S. Rossol
OBJECTIVE: To examine the intrathecal production of a newly identified cytokine, interferon-gamma-inducing factor (IL-18), together with interferon-gamma itself, in inflammatory diseases of the CNS (i.e., bacterial meningitis, viral meningoencephalitis, and MS). - RESULTS: IL-18 concentrations in CSF were significantly increased in bacterial meningitis and tended toward increased levels in viral meningoencephalitis. In contrast, IL-18 was detectable only in a few patients with MS and healthy controls. Interestingly, interferon-gamma was significantly increased selectively in CSF of patients with viral meningoencephalitis. - CONCLUSION: The observation of an intrathecal release of IL-18 in patients with meningitis argues for a pathophysiologic role of this novel cytokine in immunity against invading microorganisms the CNS..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
September 1, 1999 1999 |
---|---|
Erschienen: |
September 1, 1999 |
Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
---|---|
Enthalten in: |
Neurology - 53(1999), 5, Seite 1104-1106 |
Sprache: |
Englisch |
---|
Weiterer Titel: |
Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases |
---|
Beteiligte Personen: |
Faßbender, Klaus [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Adult |
---|
Anmerkungen: |
Gesehen am 27.07.2022 |
---|
Umfang: |
3 |
---|
doi: |
10.1212/wnl.53.5.1104 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1811810926 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1811810926 | ||
003 | DE-627 | ||
005 | 20230427152903.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220727s1999 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1212/wnl.53.5.1104 |2 doi | |
035 | |a (DE-627)1811810926 | ||
035 | |a (DE-599)KXP1811810926 | ||
035 | |a (OCoLC)1341464554 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Faßbender, Klaus |e verfasserin |0 (DE-588)1230477322 |0 (DE-627)1752917693 |4 aut | |
245 | 1 | 0 | |a Interferon-γ-inducing factor (IL-18) and interferon-γ in inflammatory CNS diseases |c K. Fassbender, O. Mielke, T. Bertsch, F. Muehlhauser, M. Hennerici, M. Kurimoto, and S. Rossol |
246 | 3 | 3 | |a Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases |
264 | 1 | |c September 1, 1999 | |
300 | |a 3 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 27.07.2022 | ||
520 | |a OBJECTIVE: To examine the intrathecal production of a newly identified cytokine, interferon-gamma-inducing factor (IL-18), together with interferon-gamma itself, in inflammatory diseases of the CNS (i.e., bacterial meningitis, viral meningoencephalitis, and MS). - RESULTS: IL-18 concentrations in CSF were significantly increased in bacterial meningitis and tended toward increased levels in viral meningoencephalitis. In contrast, IL-18 was detectable only in a few patients with MS and healthy controls. Interestingly, interferon-gamma was significantly increased selectively in CSF of patients with viral meningoencephalitis. - CONCLUSION: The observation of an intrathecal release of IL-18 in patients with meningitis argues for a pathophysiologic role of this novel cytokine in immunity against invading microorganisms the CNS. | ||
650 | 4 | |a Adult | |
650 | 4 | |a Aged | |
650 | 4 | |a Aged, 80 and over | |
650 | 4 | |a Central Nervous System Diseases | |
650 | 4 | |a Female | |
650 | 4 | |a Humans | |
650 | 4 | |a Inflammation | |
650 | 4 | |a Interferon-gamma | |
650 | 4 | |a Interleukin-18 | |
650 | 4 | |a Male | |
650 | 4 | |a Meningitis, Bacterial | |
650 | 4 | |a Meningoencephalitis | |
650 | 4 | |a Middle Aged | |
650 | 4 | |a Multiple Sclerosis | |
700 | 1 | |a Mielke, Orell |d 1967- |e verfasserin |0 (DE-588)122371984 |0 (DE-627)705882632 |0 (DE-576)293242038 |4 aut | |
700 | 1 | |a Bertsch, Thomas |e verfasserin |0 (DE-588)105441193X |0 (DE-627)791504999 |0 (DE-576)410254835 |4 aut | |
700 | 1 | |a Muehlhauser, F. |e verfasserin |4 aut | |
700 | 1 | |a Hennerici, Michael G. |d 1948- |e verfasserin |0 (DE-588)11587545X |0 (DE-627)077527704 |0 (DE-576)290126444 |4 aut | |
700 | 1 | |a Kurimoto, M. |e verfasserin |4 aut | |
700 | 1 | |a Rossol, Siegbert |e verfasserin |0 (DE-588)1106566408 |0 (DE-627)863173241 |0 (DE-576)179083627 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neurology |d Philadelphia, Pa. : Wolters Kluwer, 1951 |g 53(1999), 5, Seite 1104-1106 |h Online-Ressource |w (DE-627)302718524 |w (DE-600)1491874-2 |w (DE-576)079876609 |x 1526-632X |7 nnns |
773 | 1 | 8 | |g volume:53 |g year:1999 |g number:5 |g pages:1104-1106 |g extent:3 |
856 | 4 | 0 | |u https://doi.org/10.1212/wnl.53.5.1104 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_101 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_120 | ||
912 | |a GBV_ILN_374 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
936 | u | w | |d 53 |j 1999 |e 5 |h 1104-1106 |g 3 |
951 | |a AR | ||
952 | |d 53 |j 1999 |e 5 |h 1104-1106 |g 3 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 4173138954 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 27-07-22 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd1999 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_7 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_3 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1752917766 |a Faßbender, Klaus | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_1 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1800832885 |a Mielke, Orell | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_2 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s p |0 (DE-627)1480254908 |a Bertsch, Thomas | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1416467254 |a Medizinische Fakultät Mannheim | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |a pos_3 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s p |0 (DE-627)1440038317 |a Hennerici, Michael G. | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s k |0 (DE-627)1416467254 |a Medizinische Fakultät Mannheim | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |a pos_5 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s p |0 (DE-627)1544247613 |a Rossol, Siegbert | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s k |0 (DE-627)1416468471 |a II. Medizinische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |a pos_7 |